Ocshner HMO limiting Claritin scripts to 10 days of therapy under antihistamine guidelines.
OCSHNER HEALTH PLAN CLARITIN SCRIPTS LIMITED TO 10 DAYS OF THERAPY per month under guidelines the Metairie, La. HMO is implementing for antihistamine therapies used by its patients, VP-Pharmacy Services Daniel Lewis told the American Society of Health-System Pharmacists' mid-year clinical meeting Dec. 11 in New Orleans. Schering-Plough's Claritin is covered as third-line therapy by Ocshner. Patients on the once-daily version of Claritin (loratadine) are allowed 10 pills, while patients on twice-daily Claritin D (loratadine plus pseudoephedrine) can have 20, Lewis said.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth